search
  • Country
    Clear
  • Thematic
    Clear
  • Type
  • Compatibility Level
  • Jurisdiction
3,085 Data sources

  • ES
  • NL
  • SG
  • Thematic: No

  • more_vert
  • This is the institutional repository of Universitat de Vic - Universitat Central de Catalunya. It provides access to the work of staff and students and the interface is available in Catalan, Spanish and English.

    more_vert
  • This is the institutional repository of Universitat Rovira i Virgili. The interface is available in Spanish, Catalan and English.

    more_vert
  • more_vert
  • This site is an institutional repository which provides open access to the publications produced by the members of the University. The interface is in Spanish.

    more_vert
  • This site provides access to the research outputs of the Universidad Villanueva. Users may set up RSS feeds to be alerted to new content. The interface is available in English and Spanish.

    more_vert
  • more_vert
  • FCP is a publicly accessible web tool dedicated to analysing the current state and trends on the population of available structures along the classification schemes of enzymes and nuclear receptors, offering both graphical and quantitative data on the degree of functional coverage in that portion of the proteome by existing structures, as well as on the bias observed in the distribution of those structures among proteins.

    more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • chevron_left
  • 1
  • 2
  • 3
  • 4
  • 5
  • chevron_right
3,085 Data sources
  • more_vert
  • This is the institutional repository of Universitat de Vic - Universitat Central de Catalunya. It provides access to the work of staff and students and the interface is available in Catalan, Spanish and English.

    more_vert
  • This is the institutional repository of Universitat Rovira i Virgili. The interface is available in Spanish, Catalan and English.

    more_vert
  • more_vert
  • This site is an institutional repository which provides open access to the publications produced by the members of the University. The interface is in Spanish.

    more_vert
  • This site provides access to the research outputs of the Universidad Villanueva. Users may set up RSS feeds to be alerted to new content. The interface is available in English and Spanish.

    more_vert
  • more_vert
  • FCP is a publicly accessible web tool dedicated to analysing the current state and trends on the population of available structures along the classification schemes of enzymes and nuclear receptors, offering both graphical and quantitative data on the degree of functional coverage in that portion of the proteome by existing structures, as well as on the bias observed in the distribution of those structures among proteins.

    more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • chevron_left
  • 1
  • 2
  • 3
  • 4
  • 5
  • chevron_right